logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Hanson Pharmaceutical (03692.HK) will distribute an interim dividend of HK$0.2316 per share on October 30th.

date
18/08/2025
The Wisdom Financial APP reports that Hanson Pharmaceuticals (03692.HK) announced that it will distribute a mid-term dividend of HK$0.2316 per share on October 30, 2025.
Latest
2 m ago
The Shenzhen Stock Exchange launched a survey on the optimization of the margin account shareholder voting mechanism, involving the feasibility of setting up a dedicated voting channel.
3 m ago
Tianshan shares (000877.SZ) released its first-half performance, with a net loss attributable to shareholders of 922 million yuan.
4 m ago
In the first seven months, the national railway transported 2.331 billion tons of goods, an increase of 3.3% year-on-year.
5 m ago
Zhongke Feice (688361.SH) released its first half year performance report, showing a net loss attributable to parent company of 18.3543 million yuan.
6 m ago
Buy 430 bitcoins from August 11th to August 17th.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.